Bottom Line: Depression has been associated with poorer medical outcomes for patients with acute coronary syndrome (ACS), including heart attack and unstable angina. This randomized clinical trial of 300 patients in South Korea examined whether antidepressant treatment after ACS improved long-term cardiac outcomes. Patients received either the antidepressant escitalopram or placebo for 24 weeks. After about eight years of follow-up, the antidepressant escitalopram resulted in a lower occurrence of major adverse cardiac events than placebo (40.9 percent vs. 53.6 percent).
Authors: Jae-Min Kim, M.D., Ph.D., Chonnam National University Medical School, Gwangju, Republic of Korea, and co-authors
Visual Abstract: This is the link to the abstract when the embargo lifts.
To Learn More: The full study is available on the For The Media website.
(doi:10.1001/jama.2018.9422)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
###
Want to embed a link to this study in your story? Link will be live at the embargo time: http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.9422
Media Contact
Jae-Min Kim, M.D., Ph.D.
[email protected]
@JAMA_current
Jae-Min Kim, M.D., Ph.D.
[email protected]
@JAMA_current
